ICU
SeaStar Medical Holding Corporation
NASDAQ: ICU · HEALTHCARE · BIOTECHNOLOGY
$4.14
+6.98% today
Updated 2026-04-30
Market cap
$15.22M
P/E ratio
—
P/S ratio
12.33x
EPS (TTM)
$-5.86
Dividend yield
—
52W range
$2 – $13
Volume
0.2M
SeaStar Medical Holding Corporation (ICU) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-5.57M | $-5.11M | $-7.79M | $-10.29M | $-16.01M | $-13.60M |
| Capital expenditures | $5.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $16.00 | $14000.00 | $1.31M | $1.93M | $887000.00 | $624000.00 |
| Free cash flow | $-5.57M | $-5.11M | $-7.79M | $-10.29M | $-16.01M | $-13.60M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |